Researchers use new “spheroids” to rapidly test thousands of potential cancer-fighting compounds.
New research opens the door to studying common brain conditions such as autism, schizophrenia, addiction and Alzheimer’s disease.
With the funding, Gavin Rumbaugh and colleagues can move forward with research into brain circuitry in autism.
Chemist Floyd Romesberg tackles biological problems and new technologies to develop drugs.
Among Lansing’s current priorities as an advocate and philanthropist is the acceleration of cancer research.
As CEO of Gilead, a position he held for 20 years, Martin led the development of HIV and hepatitis therapeutics, overseeing the expansion of the company’s drug portfolio to 24 marketed products.